Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM

Clinical trial NCT05186818 · COMPLETED

Trial details

NCT number: NCT05186818
Sponsor: Cytokinetics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Obstructive Hypertrophic Cardiomyopathy (oHCM)

Start date: 2022-02-01
Primary completion: 2023-11-10
Enrollment: 282

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.